Cargando…
Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives
Platinum (Pt)-based anticancer drugs such as cisplatin have been used to treat various cancers. However, they have some limitations including poor selectivity and toxicity towards normal cells and increasing chemoresistance. Therefore, there is a need for novel metallo-anticancers, which has not bee...
Autores principales: | Lee, Sang Yeul, Kim, Chul Young, Nam, Tae-Gyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721113/ https://www.ncbi.nlm.nih.gov/pubmed/33299303 http://dx.doi.org/10.2147/DDDT.S275007 |
Ejemplares similares
-
Ruthenium(II) and Iridium(III) Complexes as Tested Materials for New Anticancer Agents
por: Masternak, Joanna, et al.
Publicado: (2020) -
Anticancer Ruthenium Complexes with HDAC Isoform Selectivity
por: Cross, Jasmine M., et al.
Publicado: (2020) -
Anticancer evaluation of new organometallic ruthenium(ii) flavone complexes
por: Khater, Mai, et al.
Publicado: (2022) -
Editorial of Special Issue Ruthenium Complex: The Expanding Chemistry of the Ruthenium Complexes
por: Dragutan, Ileana, et al.
Publicado: (2015) -
Recent Advances on Octahedral Polypyridyl Ruthenium(II) Complexes as Antimicrobial Agents
por: Yang, Yulin, et al.
Publicado: (2018)